Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Boston Scientific To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Boston Scientific between July 23, 2025 and February 3, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - April 12, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX) and reminds investors of the May 4, 2026 deadline to seek the role of lead plaintiff in a federal securities class action... Read more
Boston Scientific Corporation
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Boston Scientific Corporation (BSX) Business News
Track Boston Scientific Corporation in real time with a live news feed covering Boston Scientific Corporation stock news, official press releases, company announcements, and an archive of historical Boston Scientific Corporation news. ...more
- Learn more about Boston Scientific Corporation’s Revenue, CEO Salary, Employees, Revenue by Segment and Ownership.
- Check out competitors to Boston Scientific Corporation in a side-by-side comparison.
- Explore additional financials, or market metrics (e.g., Market cap, PE ratio, Dividend).
- Access Company Filings & Reports for the latest updates.
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
Loading news...
BOSTON SCIENTIFIC CORPORATION (BSX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline
Portnoy Law Firm Announces Class Action on Behalf of Boston Scientific Corporation Investors
BSX Shareholder Alert: Boston Scientific Corporation Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX)
BSX Fairly Valued by DCF at $50
Portnoy Law Firm Announces Class Action on Behalf of Boston Scientific Corporation Investors
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm
BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX
BSX Shareholder Alert: Boston Scientific Corporation Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm
Loading more...
BOSTON SCIENTIFIC CORPORATION (BSX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline
11:14 AM | Tuesday | Apr 14, 2026
New York, New York--(Newsfile Corp. - April 14, 2026) - Bernstein Liebhard LLP:Do you, or did you, own shares of
Read full articleNo data available for this time period.
Change the time range to see results.
BOSTON SCIENTIFIC CORPORATION (BSX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline
Newsfile CorpNew York, New York--(Newsfile Corp. - April 14, 2026) - Bernstein Liebhard LLP:Do you, or did you, own shares of
Read full article
Portnoy Law Firm Announces Class Action on Behalf of Boston Scientific Corporation Investors
GlobeNewsWireLOS ANGELES, April 14, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Boston Scientific Corporation, (“Boston Scientific” or the "Company") (NYSE: BSX) investors off a class action on behalf of investors that bought securities between July 3, 2025 and February 3, 2026, inclusive (the “Class Period”). Boston Scientific investors have until May 4, 2026 to file a lead plaintiff motion.
Read full article
BSX Shareholder Alert: Boston Scientific Corporation Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm
PRNewsWireNEW YORK, April 14, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Boston Scientific Corporation (NYSE: BSX). Shareholders who purchased shares of BSX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Read full article
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX)
GlobeNewsWireBoston Scientific Shareholders Between July 23, 2025 and February 3, 2026 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
Read full article
BSX Fairly Valued by DCF at $50
GuruFocusOn April 14, 2026, we present a DCF analysis for Boston Scientific Corp (BSX), a company that has experienced significant price fluctuations recently. The stock
Read full article
Portnoy Law Firm Announces Class Action on Behalf of Boston Scientific Corporation Investors
GlobeNewsWireLOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Boston Scientific Corporation, (“Boston Scientific” or the "Company") (NYSE: BSX) investors off a class action on behalf of investors that bought securities between July 3, 2025 and February 3, 2026, inclusive (the “Class Period”). Boston Scientific investors have until May 4, 2026 to file a lead plaintiff motion.
Read full article
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewsWireNew class action for Boston Scientific (BSX) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/4/2026
Read full article
BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026
Newsfile Corp
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX
Newsfile CorpNew York, New York--(Newsfile Corp. - April 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between July 23, 2025 and February 3, 2026, inclusive (the "Class Period"), of the important May 4, 2026 lead plaintiff deadline. SO WHAT: If you purchased Boston Scientific common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Read full article
BSX Shareholder Alert: Boston Scientific Corporation Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm
GlobeNewsWireNEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Boston Scientific Corporation (NYSE: BSX). Shareholders who purchased shares of BSX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Read full article
No data available for this time period.
Change the time range to see results.





